Looking for Mukka Proteins Share Price Targets for 2024 to 2030. To know how the stock will perform in the upcoming years, read the complete detailed analysis.
What is Mukka Proteins Ltd.?
Mukka Proteins Limited, established in 2003, oversees the production of fish protein products including fish meal, fish oil, and fish soluble paste. These products cater to various industries such as aqua feed, poultry feed, pet food, pharmaceuticals, soap, leather, and paint.
The company exports to 10 countries including Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam.
Operations encompass six manufacturing facilities, four in India and two managed by its foreign subsidiary, Ocean Aquatic Proteins LLC, located in Oman.
Additionally, Mukka Proteins manages three blending facilities and five storage facilities strategically located near the Indian coastline. The Managing Director is Mr. Kalandan Mohammed Haris.
Mukka Proteins Ltd. Fundamental Analysis
| Market Cap | ₹ 1,144.50 Cr. |
| Enterprise Value | ₹ 1,354.14 Cr. |
| No. of Shares | 30 Cr. |
| P/E | 29.03 |
| P/B | 3.31 |
| Face Value | ₹ 1 |
| Div. Yield | 0 % |
| Book Value (TTM) | ₹ 11.52 |
| Cash | ₹ 23.03 Cr. |
| Debt | ₹ 232.67 Cr. |
| Promoter Holding | 73.33 % |
| EPS (TTM) | ₹ 1.31 |
| Sales Growth | 53.91% |
| ROE | 38.66 % |
| ROCE | 23.54% |
| Profit Growth | 98.90% |
Mukka Proteins Ltd. Profit & Loss Report
| Discription | MAR 2019 | MAR 2020 | MAR 2021 | MAR 2022 | MAR 2023 |
|---|---|---|---|---|---|
| Net Sales (Cr.) | 407.37 | 545.72 | 536.25 | 692.89 | 1,066.40 |
| Total Expenditure | 382.63 | 525.66 | 529.39 | 660.37 | 1,000.73 |
| Operating Profit | 24.74 | 20.07 | 6.86 | 32.52 | 65.67 |
| Other Income | 3.01 | 8.14 | 9.15 | 7.74 | 8.87 |
| Interest | 4.34 | 6.59 | 6.95 | 8.35 | 15.18 |
| Depreciation | 2.20 | 2.80 | 3.00 | 3.72 | 4.27 |
| Exceptional Items | -0.69 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Before Tax | 20.53 | 18.82 | 6.06 | 28.20 | 55.10 |
| Tax | 5.12 | 5.98 | 1.45 | 8.38 | 15.67 |
| Net Profit | 15.41 | 12.84 | 4.61 | 19.82 | 39.42 |
| Adjusted EPS (Rs.) | 0.70 | 0.58 | 0.21 | 0.90 | 1.79 |
| Year | MUKKA share price target 2024 |
|---|---|
| 2024 | ₹30 to ₹150 |
The year 2024 is set to commence with MUKKA’s share price at ₹30, reflecting a strong start. As the year progresses, a significant rise is anticipated, reaching mid-year targets around ₹90.
The year-end prediction is notably bullish, with the share price potentially soaring to ₹150, buoyed by positive market trends.
Also Read: RVNL Share Price Target 2024, 2025, 2030, 2040, 2050: A Strategic Analysis
| Year | MUKKA share price target 2025 |
|---|---|
| 2025 | ₹145 to ₹350 |
Starting the year at ₹145, MUKKA’s share price in 2025 looks promising. The forecast suggests a steady performance throughout the year, with mid-year figures hovering around ₹270.
By December 2025, the share is expected to slightly adjust to a target of ₹350, assuming continued market support.
| Year | MUKKA share price target 2030 |
|---|---|
| 2030 | ₹800 to ₹1000 |
The year 2030 is forecasted to start with MUKKA shares at ₹800. The share price is anticipated to maintain a steady growth, reaching about ₹910 by mid-year.
The end-of-year target is optimistically set at ₹1000, culminating a decade of progressive performance.
Also Read: Polycab Share Price Target 2024, 2025, 2030, 2040, 2050: A Comprehensive Analysis
- PE Ratio: The Price to Earnings ratio for Mukka Proteins is 29.03, indicating a relatively high and potentially overvalued stock.
- Share Price: Mukka Proteins’ current share price is Rs 38.15. Utilizing valuation calculators can help determine whether the stock is undervalued or overvalued.
- Return on Assets (ROA): Mukka Proteins demonstrates a ROA of 9.51%, signaling a potentially concerning outlook for future performance.
- Current Ratio: With a current ratio of 1.14, Mukka Proteins showcases its ability to meet short-term liabilities with short-term assets.
- Return on Equity (ROE): Mukka Proteins boasts a ROE of 38.66%, indicating efficient profit generation from shareholder investments.
- Debt to Equity Ratio: Mukka Proteins’ D/E ratio is 1.91, suggesting a relatively low proportion of debt in its capital structure.
- Inventory Turnover Ratio: The inventory turnover ratio for Mukka Proteins is 6.11, revealing potential inefficiencies in inventory and working capital management.
- Sales Growth: Mukka Proteins reports a fair revenue growth of 53.91% in relation to its overall performance.
- Operating Margin: With an operating margin of 6.16% for the current financial year, Mukka Proteins’ operational efficiency is depicted.
- Dividend Yield: Mukka Proteins offers a dividend yield of 0%, with a current year dividend of Rs 0.
Strengths
- Demonstrated a robust revenue growth of 25.02% over the last 3 years.
- Maintained a healthy Return on Equity (ROE) of 24.55% during the same period.
- Boasts a favorable PEG ratio of 0.29.
- Exhibits an efficient Cash Conversion Cycle of 48.15 days.
- Possesses a substantial promoter holding of 73.33%.
- Demonstrates a strong degree of Operating leverage, with an average Operating leverage of 12.00.
Weakness
- Faces contingent liabilities amounting to 105.51 Cr.
- Experiences negative cash flow from operations, with a value of -46.96.
Also Read: Exicom Share Price Targets for 2024, 2025 to 2030
FAQs
Mukka Proteins expected to reach INR 100 at the end of 2024.
What is the stock price target of mukka proteins for 2025?
The stock price target of MUKKA for 2025 is between INR 145 to INR 350.
